Edition:
United Kingdom

People: Qiagen NV (QGEN.N)

QGEN.N on New York Stock Exchange

39.52USD
14 Jun 2019
Change (% chg)

$-0.10 (-0.25%)
Prev Close
$39.62
Open
$39.42
Day's High
$39.80
Day's Low
$39.40
Volume
358,362
Avg. Vol
362,081
52-wk High
$41.52
52-wk Low
$32.36

Sheldon, Jonathan 

Dr. Jonathan Sheldon has served as Senior Vice President Bioinformatics Business Area, Member of the Executive Committee of Qiagen N.V. since 2018. Joined QIAGEN in 2018 as Senior Vice President, Bioinformatics Business Area. He leads QIAGEN's growing presence in bioinformatics, enabling customers to transform raw data from biological samples into valuable molecular insights. Dr. Sheldon came to QIAGEN from Oracle, where he was Global Vice President leading Oracle's Healthcare business globally in the Health Sciences Global Business Unit and served on the executive committee. Previously, he established the bioinformatics group and served as Head of Bioinformatics at Roche (UK) Pharmaceuticals, as well as providing leadership in software firms serving the life science and healthcare sectors. He serves on the Board of Directors of the Drug Information Association (DIA). He received his B.Sc. in Biochemistry and Molecular Biology from the University of Manchester, and his Ph.D. in Biochemistry and Molecular Biology from the University of Cambridge.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --